Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

4
results for

"Clinical practice guideline"

Article category

Keywords

Publication year

"Clinical practice guideline"

Editorial

Hepatic neoplasm

Citations

Citations to this article as recorded by  Crossref logo
  • Factors Influencing Overall Survival Period of Stage IV Cancer Patients
    Wen Pei Chang, Yen Kuang Lin, Shashank Kaushik
    European Journal of Cancer Care.2025;[Epub]     CrossRef
  • 7,664 View
  • 75 Download
  • 1 Web of Science
  • Crossref
Reviews

Hepatic neoplasm

Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
Clin Mol Hepatol 2023;29(2):197-205.
Published online January 5, 2023
DOI: https://doi.org/10.3350/cmh.2022.0404
Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean Liver Cancer Association and National Cancer Center Korea Practice Guideline Revision Committee have recently revised the practice guidelines for HCC management. However, there are some differences between practice guidelines and real-life clinical practice. In this review, we describe some key recommendations of the 2022 version of practice guidelines and the real-life clinical situation in South Korea, together with discussion about efforts needed to reduce the difference between guidelines and real-life clinical practice.

Citations

Citations to this article as recorded by  Crossref logo
  • Identifying Sorafenib Benefit among Hepatocellular Carcinoma Patients: A Transcriptomic and Genomic Approach
    Sun Young Yim, Hayeon Kim, Tae Hyung Kim, Sang-Hee Kang, Youngwoo Lee, Eunho Choi, Yang Jae Yoo, Seong Hee Kang, Young-Sun Lee, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kyung Suk Yang, Yitao Tang, Bowha Sohn, Yun Seong Jeong, Hyewon P
    JHEP Reports.2026; : 101742.     CrossRef
  • Neutrophil count predicts the complete response after transarterial chemoembolization related to favorable outcome in hepatocellular carcinoma
    Young Mi Hong
    European Journal of Gastroenterology & Hepatology.2025; 37(1): 94.     CrossRef
  • Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
    Yuqi Feng, Letian Fang, Guangwen Cao
    Hepatoma Research.2025;[Epub]     CrossRef
  • A Prospective, Multicenter, Randomized, Noninferiority Trial of Stopad® Versus Tachosil® for Hemostasis After Liver Resection
    Seung Yeon Lim, Gi Hong Choi, Jin Hong Lim, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Boram Lee, Yeshong Park, MeeYoung Kang, Jinju Kim, Hyelim Joo, Jai Young Cho
    Cancers.2025; 17(5): 757.     CrossRef
  • Reply: Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of hepatocellular carcinoma
    Deok Hwa Seo, Pil Soo Sung
    Hepatology.2025; 81(4): E123.     CrossRef
  • The Association Between Hepatocellular Carcinoma and Gastrointestinal Adenocarcinoma: Is This a New Syndrome in Patients With Cirrhosis? A Case Series
    Fabrizio Bronte, Fabio D'Amato, Maria Rosa Barcellona, Giuseppe Bronte, Giuseppe Malizia, Salvatore Ialuna, Giorgio Fusco, Francesco Verderame, Enrico Bronte, Maria Grazia Bavetta
    Cancer Reports.2025;[Epub]     CrossRef
  • Roadmap for HCC Surveillance and Management in the Asia Pacific
    Masatoshi Kudo, Bui Thi Oanh, Chien-Jen Chen, Do Thi Ngat, Jacob George, Do Young Kim, Luckxawan Pimsawadi, Pisit Tangkijvanich, Raoh-Fang Pwu, Rosmawati Mohamed, Sakarn Bunnag, Sheng-Nan Lu, Sirintip Kudtiyakarn, Tatsuya Kanto, Teerha Piratvisuth, Chao-C
    Cancers.2025; 17(12): 1928.     CrossRef
  • TCR-based cellular immunotherapy for hepatocellular carcinoma: advances, challenges, and prospects
    Wanting Zeng, Wei Zhu, Guosheng Yuan, Jinzhang Chen, Zhanhui Wang, Jinlin Hou, De-Ke Jiang
    Cancer Immunology, Immunotherapy.2025;[Epub]     CrossRef
  • Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab–bevacizumab
    Heechul Nam, Dong Yun Kim, Do Young Kim, Ji Hoon Kim, Chang Wook Kim, Jaejun Lee, Keungmo Yang, Ji Won Han, Pil Soo Sung, Seung Kew Yoon, Hee Sun Cho, Hyun Yang, Si Hyun Bae, Soon Kyu Lee, Jung Hyun Kwon, Soon Woo Nam, Ahlim Lee, Do Seon Song, U Im Chang,
    Hepatology.2025;[Epub]     CrossRef
  • Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab
    Jaejun Lee, Keungmo Yang, Ji Won Han, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Hee Sun Cho, Hyun Yang, Si Hyun Bae, Ji Hoon Kim, Heechul Nam, Chang Wook Kim, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Ahlim Lee, Do Seon Song, Myeong Jun Song, Soon Woo
    Clinical Cancer Research.2025; 31(20): 4323.     CrossRef
  • Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis
    Jihoon Kim, Jin-Hyoung Kim, Byung Soo Im, Gun Ha Kim, Hee Ho Chu, Dong Il Gwon, Ji Hoon Shin, Ju Hyun Shim, Sang Min Yoon, Sehee Kim
    Cancers.2025; 18(1): 33.     CrossRef
  • The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma
    Beom Kyung Kim
    Gut and Liver.2024; 18(1): 3.     CrossRef
  • Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
    Josep M. Llovet, Roser Pinyol, Mark Yarchoan, Amit G. Singal, Thomas U. Marron, Myron Schwartz, Eli Pikarsky, Masatoshi Kudo, Richard S. Finn
    Nature Reviews Clinical Oncology.2024; 21(4): 294.     CrossRef
  • High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study
    Jun Sik Yoon, Ji Hoon Hong, Soo Young Park, Seung Up Kim, Hwi Young Kim, Ju Yeon Kim, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Han Ah Lee, Gi‐Ae Kim, Dong Hyun Sinn, Sung Jae Park, Youn Jae Lee, Yoon Jun Kim, Jung‐Hwan Yoon, Jeong‐Hoon Lee
    Alimentary Pharmacology & Therapeutics.2024; 59(8): 973.     CrossRef
  • Role of reimbursement and Physicians' awareness in the survival of sorafenib‐eligible advanced hepatocellular carcinoma patients
    Hui‐Ling Huang, Te‐Sheng Chang, Lariza Marie Canseco, Fan Wu, Sheng‐Nan Lu
    The Kaohsiung Journal of Medical Sciences.2024; 40(6): 589.     CrossRef
  • Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
    Ye Rim Kim, Sung Won Chung, Min-Ju Kim, Won-Mook Choi, Jonggi Choi, Danbi Lee, Han Chu Lee, Ju Hyun Shim
    Journal of Hepatocellular Carcinoma.2024; Volume 11: 1235.     CrossRef
  • Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
    Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang
    PLOS ONE.2024; 19(8): e0307712.     CrossRef
  • The position of loco-regional therapy in the management of hepatocellular carcinoma with extrahepatic metastases
    Beom Kyung Kim
    Journal of Liver Cancer.2024; 24(2): 129.     CrossRef
  • Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy
    Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Moon Seok Choi
    Journal of Liver Cancer.2024; 24(2): 243.     CrossRef
  • Primary treatments for solitary hepatocellular carcinoma ≤ 3 cm: A systematic review and network meta-analysis
    Sang-Hoon Kim, Ki-Hun Kim, Byeong-Gon Na, Sung Min Kim, Rak-Kyun Oh
    Annals of Hepato-Biliary-Pancreatic Surgery.2024; 28(4): 397.     CrossRef
  • Evolution of Liver Resection for Hepatocellular Carcinoma: Change Point Analysis of Textbook Outcome over Twenty Years
    Yeshong Park, Ho-Seong Han, Seung Yeon Lim, Hyelim Joo, Jinju Kim, MeeYoung Kang, Boram Lee, Hae Won Lee, Yoo-Seok Yoon, Jai Young Cho
    Medicina.2024; 61(1): 12.     CrossRef
  • A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
    Soon Kyu Lee, Jung Hyun Kwon, Sung Won Lee, Hae Lim Lee, Hee Yeon Kim, Chang Wook Kim, Do Seon Song, U Im Chang, Jin Mo Yang, Soon Woo Nam, Seok-Hwan Kim, Myeong Jun Song, Ji Hoon Kim, Ahlim Lee, Hyun Yang, Si Hyun Bae, Ji Won Han, Heechul Nam, Pil Soo Su
    Cancers.2023; 15(17): 4423.     CrossRef
  • What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
    Min Kyung Park, Yoon Jun Kim
    Clinical and Molecular Hepatology.2023; 29(2): 332.     CrossRef
  • The current trends in the health burden of primary liver cancer across the globe
    Peter Konyn, Aijaz Ahmed, Donghee Kim
    Clinical and Molecular Hepatology.2023; 29(2): 358.     CrossRef
  • Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
    Do Young Kim
    Clinical and Molecular Hepatology.2023; 29(2): 335.     CrossRef
  • A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
    Yun Bin Lee, Joon Yeul Nam, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Hyo-Cheol Kim, Jin Chul Paeng, Jung-Hwan Yoon, Yoon Jun Kim
    Clinical Cancer Research.2023; 29(18): 3650.     CrossRef
  • Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma
    Yasunori Minami, Tomoko Aoki, Satoru Hagiwara, Masatoshi Kudo
    Cancers.2023; 15(19): 4763.     CrossRef
  • 10,130 View
  • 275 Download
  • 26 Web of Science
  • Crossref

Viral hepatitis

Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee
Clin Mol Hepatol 2020;26(4):411-429.
Published online August 28, 2020
DOI: https://doi.org/10.3350/cmh.2020.0049
Clinical practice guidelines are important for guiding the management of specific diseases by medical practitioners, trainees, and nurses. In some cases, the guidelines are utilized as a reference for health policymakers in controlling diseases with a large public impact. With this in mind, practice guidelines for the management of chronic hepatitis B (CHB) have been developed in the United States, Europe, and Asian-Pacific regions to suggest the best-fit recommendations for each social and medical circumstance. Recently, the Korean Association for the Study of the Liver published a revised version of its clinical practice guidelines for the management of CHB. The guidelines included updated information based on newly available antiviral agents, the most recent opinion on the initiation and cessation of treatment, and updates for the management of drug resistance, partial virological response, and side effects. Additionally, CHB management in specific situations was comprehensively revised. This review compares the similarities and differences among the various practice guidelines to identify unmet needs and improve future recommendations.

Citations

Citations to this article as recorded by  Crossref logo
  • Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B
    David Z Pan, Cameron M Soulette, Abhishek Aggarwal, Dong Han, Nicholas van Buuren, Peiwen Wu, Becket Feierbach, Jaw-Town Lin, Cheng-Hao Tseng, Chi-Yi Chen, Bryan Downie, Hongmei Mo, Lauri Diehl, Li Li, Simon P Fletcher, Scott Balsitis, Ricardo Ramirez, Vi
    Gut.2025; 74(4): 628.     CrossRef
  • Limited Value of HBV‐RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg‐negative Hepatitis B Patients
    Valerie Ohlendorf, Maximilian Wübbolding, Christoph Höner zu Siederdissen, Birgit Bremer, Katja Deterding, Heiner Wedemeyer, Markus Cornberg, Benjamin Maasoumy
    Journal of Viral Hepatitis.2025;[Epub]     CrossRef
  • Overview of chronic hepatitis B management
    Angela Jun, Sherona Bau, John S. Kim, Susanne J. Phillips
    The Nurse Practitioner.2025; 50(1): 7.     CrossRef
  • Effectiveness and safety of tenofovir amibufenamide and tenofovir alafenamide in treating elderly patients diagnosed with decompensated hepatitis B cirrhosis: a retrospective cohort study
    Xinye Qiu, Yue Yin, Shibin Zhang, Wei Liu
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Decreased incidence of hepatocellular carcinoma in non‐cirrhotic and low‐viral‐load chronic hepatitis B patients treated with nucleotide/nucleoside analogs
    Tyng‐Yuan Jang, Chia‐Yen Dai
    Advances in Digestive Medicine.2025;[Epub]     CrossRef
  • Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021
    Pojsakorn Danpanichkul, Kwanjit Duangsonk, Vincent L. Chen, Preenapun Saokhieo, Disatorn Dejvajara, Banthoon Sukphutanan, Majd B. Aboona, Chawin Lopimpisuth, Yanfang Pang, Andrew F. Ibrahim, Michael B. Fallon, Daniel Q. Huang, Donghee Kim, Amit G. Singal,
    Hepatology.2025; 82(5): 1274.     CrossRef
  • Tenofovir alafenamide-related hyperlipidemia and cardiovascular risk
    Ankur Jindal, Manoj Kumar
    Hepatology International.2025; 19(4): 701.     CrossRef
  • Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis
    Yunmi Ko, Byeong Geun Song, Hyunjae Shin, Youngsu Park, Jeayeon Park, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Jung-Hwan Yoon, Seung Shin Park, Moon Haeng Hur, Jeong-Hoon Lee
    Osteoporosis International.2025; 36(8): 1391.     CrossRef
  • Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B
    Jae Seung Lee, Sung Won Lee, Hae Lim Lee, Jeong-Ju Yoo, Yeon Seok Seo, Su Jong Yu, Hyung Joon Yim, Young Kul Jung, Jisu Moon, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Sang Gyune Kim, Seung Up Kim
    Scientific Reports.2025;[Epub]     CrossRef
  • Time for a globally unified chronic HBV terminology?
    Su Wang, Catherine Freeland, Seng Gee Lim, Hailemichael Desalegn, Chari Cohen, Harry L.A. Janssen
    JHEP Reports.2025; 7(12): 101570.     CrossRef
  • Chronic hepatitis B: Is it time for expanded antiviral treatment?
    Manish Manrai, Atul A Jha, Aditya V Pachisia, Saurabh Dawra
    World Journal of Virology.2025;[Epub]     CrossRef
  • Modeling the Impact of Treatment on Hepatitis B Burden: Mathematical Analysis and Simulation
    Jean Pierre II Kouenkam, Joseph Mbang, Gilbert Chendjou, Herieth Rwezaura, Jean Tchuenche
    Operations Research Forum.2025;[Epub]     CrossRef
  • Efficacy and safety of PEG-IFN α-2b and tenofovir amibufenamide in combination therapy for chronic hepatitis B
    Wen Zhao, Longcan Li, Shihui Liu, Wenjie Zhang, Yufeng Gao, Zonghao Zhao, Xiaojun Liu, Yi Luo, Dongdong Li, Chuanmiao Liu
    BMC Infectious Diseases.2025;[Epub]     CrossRef
  • Precision Management of Patients with HBV Infection
    Chih-Lin Lin, Jia-Horng Kao
    Current Hepatology Reports.2024; 23(1): 22.     CrossRef
  • Management of Hepatitis B in Pregnancy
    Jeanette Rios, Lital Aliasi-Sinai, Natalia Schmidt, Tatyana Kushner
    Current Hepatology Reports.2024; 23(2): 278.     CrossRef
  • Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B
    Tae Hyung Kim, Ji Hoon Kim, Hyung Joon Yim, Yeon Seok Seo, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun
    Gut and Liver.2024; 18(2): 305.     CrossRef
  • Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B
    Heechul Nam, Ji Won Han, Soon Kyu Lee, Hyun Yang, Hae Lim Lee, Pil Soo Sung, Myeong Jun Song, Jung Hyun Kwon, Jeong Won Jang, U‐Im Chang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jin Mo Yang, Hee Yeon Kim
    Journal of Gastroenterology and Hepatology.2024; 39(8): 1673.     CrossRef
  • Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
    Tyng‐Yuan Jang, Batbold Batsaikhan, Yo‐Chia Chen, Chia‐Yen Dai
    Journal of Gastroenterology and Hepatology.2024; 39(11): 2327.     CrossRef
  • Modern etiotropic therapy of chronic viral hepatitis B
    E. B. Bun'kova, N. A. Bileva, A. E. Bilev, M. I. Sinel'nikov
    Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2024; 14(4): 76.     CrossRef
  • Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients
    Wei-Chun Lin, Ke Lin, Ming-Kai Li, Xiao Liu, Yi-Fei Huang, Xing Wang, Bin Wu
    World Journal of Hepatology.2024; 16(11): 1321.     CrossRef
  • Safety and efficacy of 48-week pegylated interferon-α-2b therapy in patients with hepatitis B virus-related compensated liver cirrhosis: a pilot observational study
    Zehong Wang, Xuanxuan Wang, Li Zhou, Shaoyuan Shi, Yongli Hua, Yinong Feng
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Limited stability of Hepatitis B virus RNA in plasma and serum
    Valerie Ohlendorf, Birgit Bremer, Lisa Sandmann, Carola Mix, Tammo Tergast, Markus Cornberg, Heiner Wedemeyer, Katja Deterding, Benjamin Maasoumy
    Scientific Reports.2024;[Epub]     CrossRef
  • Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate
    Shenglong Lin, Wanlong Huang, Ziyuan Liao, Huaxi Ma, Wenjun Wu, Minghua Lin, Defu Huang, Haibing Gao
    Scientific Reports.2024;[Epub]     CrossRef
  • Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study
    Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
    European Journal of Internal Medicine.2023; 107: 66.     CrossRef
  • Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study
    Byungyoon Yun, Juyeon Oh, Sang Hoon Ahn, Jin-Ha Yoon, Beom Kyung Kim
    American Journal of Gastroenterology.2023; 118(6): 1001.     CrossRef
  • Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
    Won Sohn, Yong-Han Paik
    Clinical and Molecular Hepatology.2023; 29(1): 182.     CrossRef
  • Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study
    Yoonseok Lee, Seryun Bae, Ji Hoon Kim, Minjung Kwak, So Yeon Jeon, Taehyung Kim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
    Journal of Clinical Medicine.2023; 12(2): 712.     CrossRef
  • Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
    Han Ah Lee, Seung Up Kim, Yeon Seok Seo, Sang Hoon Ahn, Chai Hong Rim
    Hepatology Communications.2023; 7(2): e0011.     CrossRef
  • miR-548c-3p targets TRIM22 to attenuate the Peg–IFN–α therapeutic efficacy in HBeAg-positive patients with chronic hepatitis B
    Ni Lin, Long Wang, Zhaopei Guo, Shaoying Guo, Can Liu, Jinpiao Lin, Songhang Wu, Siyi Xu, Hongyan Guo, Fenglin Fang, Ya Fu, Qishui Ou
    Antiviral Research.2023; 213: 105584.     CrossRef
  • Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
    Xingxin Zhang, Chenjian Gu, Qian Wei, Yirong Cao, Weimin She, Hong Shi, Youhua Xie, Jinsheng Guo
    Journal of Hepatocellular Carcinoma.2023; Volume 10: 599.     CrossRef
  • Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
    Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
    Clinical and Molecular Hepatology.2023; 29(2): 482.     CrossRef
  • Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
    Daniel Q. Huang, Nobuharu Tamaki, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Hye Won Lee, Seng Gee Lim, Tae Seop Lim, Masayuki Kurosaki, Hiroyuki Marusawa, Toshie Mashiba, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Namiki Izumi,
    Hepatology.2023; 77(5): 1746.     CrossRef
  • Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
    Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
    Alimentary Pharmacology & Therapeutics.2023; 58(1): 99.     CrossRef
  • The urgency to expand the antiviral indications of general chronic hepatitis B patients
    Ping Fan, Lan-Qing Li, En-Qiang Chen
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study
    Lanqing Li, Jing Zhou, Yujing Li, Fada Wang, Dongmei Zhang, Menglan Wang, Yachao Tao, Enqiang Chen
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study
    Heejoon Jang, Su Jong Yu, Hong Ghi Lee, Tae Min Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
    Heejin Cho, Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
    Beom Kyung Kim, Sang Hoon Ahn
    Journal of the Formosan Medical Association.2023; 122(12): 1238.     CrossRef
  • Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
    Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
    Clinical and Molecular Hepatology.2023; 29(3): 794.     CrossRef
  • Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
    Soo Ryang Kim, Soo Ki Kim
    Diagnostics.2023; 13(20): 3212.     CrossRef
  • The Connection between MiR-122 and Lymphocytes in Patients Receiving Treatment for Chronic Hepatitis B Virus Infection
    Marina Manea, Dimitri Apostol, Ileana Constantinescu
    Microorganisms.2023; 11(11): 2731.     CrossRef
  • Patient Preferences and Their Influence on Chronic Hepatitis B-A Review
    Lin Zhang, Yunyue Liu, Jinping Tian
    Patient Preference and Adherence.2023; Volume 17: 3119.     CrossRef
  • Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR‐122
    Yuh‐Jin Liang, Yu‐Wei Chiou, Abby Pei‐Ting Chiu, Ming‐Shi Shiao, Wei Teng, Chin‐Wei Lin, Mei‐Ling Cheng, Yen‐Hua Huang, Kung‐Hao Liang, Chien‐Wei Su, Chi‐Yu Lai, Chih‐Li Chen, Jaw‐Ching Wu
    Journal of Medical Virology.2023;[Epub]     CrossRef
  • Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
    Tyng-Yuan Jang, Chi-Chang Ho, Chih-Da Wu, Chia-Yen Dai, Pau-Chung Chen
    Medicine.2023; 102(43): e34276.     CrossRef
  • Effectiveness and Safety of Tenofovir Alafenamide in Treatment-Naïve and Treatment-Experienced Patients with Chronic Hepatitis B: Results of a Real-World Study from China
    Lan-Qing Li, Fa-Da Wang, Jing Zhou, Meng-Lan Wang, Yachao Tao, En-Qiang Chen
    Hepatitis Monthly.2023;[Epub]     CrossRef
  • Influence of Renal Function on the Single‐Dose Pharmacokinetics of Besifovir, a Novel Antiviral Agent for theTreatment of Hepatitis B Virus Infection
    Jun Gi Hwang, Yu Kyong Kim, Young‐sim Choi, Soon Kil Kwon, Joung‐Ho Han, Min Kyu Park
    The Journal of Clinical Pharmacology.2022; 62(1): 46.     CrossRef
  • Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection
    Zhenyu Zhong, Weiting Liao, Lingyu Dai, Xiaojie Feng, Guannan Su, Yu Gao, Qiuying Wu, Peizeng Yang
    Annals of the Rheumatic Diseases.2022; 81(4): 584.     CrossRef
  • Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
    Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    American Journal of Gastroenterology.2022; 117(2): 288.     CrossRef
  • Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study
    Anil Alpsoy, Haydar Adanir, Zeynep Bayramoglu, Gulsum Ozlem Elpek
    World Journal of Hepatology.2022; 14(1): 260.     CrossRef
  • External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
    Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Cancers.2022; 14(3): 711.     CrossRef
  • Translational Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and Management in East Asian Countries
    Ben Kang, Dae Yong Yi, Byung-Ho Choe
    Frontiers in Pediatrics.2022;[Epub]     CrossRef
  • Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis
    Seunghwan Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Diagnostics.2022; 12(2): 441.     CrossRef
  • Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study
    Young Eun Chon, Soo Young Park, Seung Up Kim, Han Pyo Hong, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Journal of Viral Hepatitis.2022; 29(4): 289.     CrossRef
  • A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients
    Hyung Joon Kim, Ju Hyun Kim, Jong Eun Yeon, Yeon Seok Seo, Jeong Won Jang, Yong Kyun Cho, Byoung Kuk Jang, Byung Hoon Han, Changhyeong Lee, Joon Hyeok Lee, Jung-Hwan Yoon, Kang Mo Kim, Moon Young Kim, Do Young Kim, Neung Hwa Park, Eun Young Cho, June Sung
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients
    Han Ah Lee, Hyun Woong Lee, Younhee Park, Hyon-Suk Kim, Yeon Seok Seo
    Journal of Clinical Medicine.2022; 11(6): 1729.     CrossRef
  • Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL
    Hankil Lee, Sungin Jang, Sang Hoon Ahn, Beom Kyung Kim
    Hepatology International.2022; 16(2): 294.     CrossRef
  • KASL clinical practice guidelines for management of chronic hepatitis B

    Clinical and Molecular Hepatology.2022; 28(2): 276.     CrossRef
  • Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study
    Byungyoon Yun, Sang Hoon Ahn, Jin-Ha Yoon, Beom Kyung Kim
    American Journal of Gastroenterology.2022; 117(5): 758.     CrossRef
  • Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk
    David Sooik Kim, Beom Kyung Kim, Yeon Seok Seo, Byung Seok Kim, Byoung Kuk Jang, Sang Gyune Kim, Ki Tae Suk, Jin‐Woo Lee, Soung Won Jeong, Seung Up Kim
    Liver International.2022; 42(8): 1902.     CrossRef
  • Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study
    Jihye Lim, Jung‐Bok Lee, Jihyun An, Gi‐Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
    Journal of Viral Hepatitis.2022; 29(9): 756.     CrossRef
  • Statin use and risk of progression to liver cirrhosis in chronic hepatitis B independent of conventional risk factors: A nationwide study
    Byungyoon Yun, Sang Hoon Ahn, Jin‐Ha Yoon, Beom Kyung Kim
    Hepatology Communications.2022; 6(9): 2455.     CrossRef
  • Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma
    Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
    European Journal of Internal Medicine.2022; 103: 122.     CrossRef
  • [Retracted] Finite versus Indefinite Nucleos(t)ide Analogue Therapy of Patients with Chronic Hepatitis B Exhibiting Negative HBsAg Levels after Treatment
    Haixia Sun, Yinhui Liu, Yufeng Zhang, Yusheng Jie, Yuankai Wu, Zhanyi Li, Xuxia Wei, Xiangyong Li, Bing Niu
    BioMed Research International.2022;[Epub]     CrossRef
  • Validation of Hepatocellular Carcinoma Risk Prediction Models in Patients with Hepatitis B-Related Cirrhosis
    Ran Cheng, Xiaoyuan Xu
    Journal of Hepatocellular Carcinoma.2022; Volume 9: 987.     CrossRef
  • Response to Liao et al.
    Byungyoon Yun, Jin-Ha Yoon, Beom Kyung Kim
    American Journal of Gastroenterology.2022; 117(10): 1718.     CrossRef
  • Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
    Hyung Joon Yim, Ji Hoon Kim, Yong Kyun Cho, Young Oh Kweon, Hyun Chin Cho, Jae Seok Hwang, Changhyeong Lee, Moon Soo Koh, Yang-Hyun Baek, Young-Min Park, Jeong-Hoon Lee, Seung Up Kim, Min-Kyu Kang, Neung Hwa Park, June Sung Lee, Young Eun Chon, Gab Jin Ch
    Drug Design, Development and Therapy.2022; Volume 16: 3263.     CrossRef
  • Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
    Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
    Cancers.2022; 14(20): 5002.     CrossRef
  • Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients
    Ji Hun Lee, Seung Kak Shin, Seong Hee Kang, Tae Hyung Kim, Hyung Joon Yim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Oh Sang Kwon, Soon Ho Um, Kwan Soo Byun
    Journal of Clinical Medicine.2022; 11(22): 6613.     CrossRef
  • Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis
    Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun
    Clinical and Molecular Hepatology.2022; 28(4): 876.     CrossRef
  • Secondary prevention of hepatitis B virus‐related hepatocellular carcinoma with current antiviral therapies
    Jonggi Choi, Young‐Suk Lim
    The Kaohsiung Journal of Medical Sciences.2021; 37(4): 262.     CrossRef
  • External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
    Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Journal of Viral Hepatitis.2021; 28(6): 951.     CrossRef
  • Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
    Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
    Cancers.2021; 13(14): 3424.     CrossRef
  • No Uniformity in the References of Clinical Practice Guidelines for Bariatric Surgery: a Review of 3 Similar Guidelines Published in 2020.
    Mark J. R. Smeets, Ronald S. L. Liem
    Obesity Surgery.2021; 31(12): 5427.     CrossRef
  • Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
    Hepatology International.2021; 15(5): 1083.     CrossRef
  • Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
    Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
    Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123.     CrossRef
  • The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
    Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
  • Critical Updates on Chronic Hepatitis B Virus Infection in 2021
    Cyriac A Philips, Rizwan Ahamed, Jinsha K Abduljaleel, Sasidharan Rajesh, Philip Augustine
    Cureus.2021;[Epub]     CrossRef
  • Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
    David Sooik Kim, Soo Young Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Yu Rim Lee, Won Young Tak, Young Oh Kweon, Inkyung Jung, Minkyung Han, Eun Hwa Kim, Sang Hoon Ahn, Seung Up Kim
    Journal of Korean Medical Science.2021;[Epub]     CrossRef
  • Novel Therapies of Hepatitis B and D
    Iman Waheed Khan, Mati Ullah Dad Ullah, Mina Choudhry, Mukarram Jamat Ali, Muhammad Ashar Ali, Sam L. K. Lam, Pir Ahmad Shah, Satinder Pal Kaur, Daryl T. Y. Lau
    Microorganisms.2021; 9(12): 2607.     CrossRef
  • Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B
    Yoon Seok Lee, Soo Min Bang, Young-Sun Lee
    Journal of Clinical Medicine.2021; 10(11): 2320.     CrossRef
  • Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
    Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
    Journal of Viral Hepatitis.2021; 28(11): 1570.     CrossRef
  • Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Hye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Dong Hyun Sinn, Seung Up Kim
    Hepatology International.2021; 15(6): 1328.     CrossRef
  • Progress and challenges in the comprehensive management of chronic viral hepatitis: Key ways to achieve the elimination
    Fátima Higuera-de la Tijera, Alfredo Servín-Caamaño, Luis Servín-Abad
    World Journal of Gastroenterology.2021; 27(26): 4004.     CrossRef
  • Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
    Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Cancers.2021; 13(23): 5892.     CrossRef
  • 20,173 View
  • 1,482 Download
  • 84 Web of Science
  • Crossref
Revision and update on clinical practice guideline for liver cirrhosis
Ki Tae Suk, Soon Koo Baik, Jung Hwan Yoon, Jae Youn Cheong, Yong Han Paik, Chang Hyeong Lee, Young Seok Kim, Jin Woo Lee, Dong Joon Kim, Sung Won Cho, Seong Gyu Hwang, Joo Hyun Sohn, Moon Young Kim, Young Bae Kim, Jae Geun Kim, Yong Kyun Cho, Moon Seok Choi, Hyung Joon Kim, Hyun Woong Lee, Seung Up Kim, Ja Kyung Kim, Jin Young Choi, Dae Won Jun, Won Young Tak, Byung Seok Lee, Byoung Kuk Jang, Woo Jin Chung, Hong Soo Kim, Jae Young Jang, Soung Won Jeong, Sang Gyune Kim, Oh Sang Kwon, Young Kul Jung, Won Hyeok Choe, June Sung Lee, In Hee Kim, Jae Jun Shim, Gab Jin Cheon, Si Hyun Bae, Yeon Seok Seo, Dae Hee Choi, Se Jin Jang
Korean J Hepatol 2012;18(1):1-21.
Published online March 22, 2012
DOI: https://doi.org/10.3350/kjhep.2012.18.1.1

Citations

Citations to this article as recorded by  Crossref logo
  • Direct bilirubin was superior to total bilirubin in predicting the long-term outcomes of patients with primary biliary cholangitis
    Sha Chen, Buer Li, Shuxiang Li, Tingting Lv, Qin Xiao, Hong Ma, Yu Wang, Xinyan Zhao, Xiaojuan Ou, Yuanyuan Kong, Hong You, Jidong Jia, Weijia Duan
    BMC Gastroenterology.2026;[Epub]     CrossRef
  • GLOBE Score and UK‐PBC Risk Score Predict Long‐Term Clinical Outcomes of Patients With Primary Biliary Cholangitis and Receiving Ursodeoxycholic Acid and Fenofibrate
    Shu Xiang Li, Bu Er Li, Min Li, Sha Chen, Ting Ting Lyu, Qian Yi Wang, Xiao Ming Wang, Yu Wang, Hong Ma, Xiao Juan Ou, Yuan Yuan Kong, Xin Yan Zhao, Hong You, Wei Jia Duan, Ji Dong Jia
    Journal of Digestive Diseases.2025; 26(5-6): 250.     CrossRef
  • Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-male-albumin-bilirubin-platelet (aMAP) and Liver Stiffness Assessed by Vibration-controlled Transient Elastography
    Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
    Clinical Gastroenterology and Hepatology.2025;[Epub]     CrossRef
  • MetaLAB‐HOI: Template standardization of health outcomes enable massive and accurate detection of adverse drug reactions from electronic health records
    Suehyun Lee, Hyunah Shin, Seon Choe, Min‐Gyu Kang, Sae‐Hoon Kim, Dong Yoon Kang, Ju Han Kim
    Pharmacoepidemiology and Drug Safety.2024;[Epub]     CrossRef
  • Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomena
    Mengqi Li, Sha Chen, Shuxiang Li, Tingting Lv, Buer Li, Shan Shan, Min Li, Na Zeng, Qianyi Wang, Yuanyuan Kong, Hong Ma, Xinyan Zhao, Xiaojuan Ou, Hong You, Weijia Duan, Jidong Jia
    Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
  • Establishment and evaluation of an early prediction model of hepatorenal syndrome in patients with decompensated hepatitis B cirrhosis
    Shouhao Wang, Zhewen Zhou, Chengan Xu, Hanzhu Chen, Wenya Ren, Xingdi Yang, Qiaoqiao Yin, Wei Zheng, Hongying Pan
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • Initial treatment response and short-term mortality of spontaneous bacterial peritonitis in cirrhotic patients with hepatocellular carcinoma
    Chang Hun Lee, Hye Jin Kang, Song Yi Yu, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, In Hee Kim
    Scientific Reports.2023;[Epub]     CrossRef
  • The Wnt/β-catenin signaling pathway plays a role in drug-induced liver injury by regulating cytochrome P450 2E1 expression
    Yoo-Sub Shin, Da-Bin Hwang, Dong-Hoon Won, Shin-Young Kim, Changuk Kim, Jun Won Park, Young Jeon, Jun-Won Yun
    Toxicological Research.2023; 39(3): 443.     CrossRef
  • Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study
    Jae-Hyun Yoon, Sung-Eun Kim, Su-Hyeon Cho, Gi-Ae Kim, Yewan Park, Ji-Won Park, Seong-Hee Kang, Young-Sun Lee, Jeong-Han Kim
    Medicina.2023; 59(8): 1436.     CrossRef
  • Concomitant gallstone disease was not associated with long‐term outcomes in ursodeoxycholic acid‐treated patients with primary biliary cholangitis
    Sha Chen, Meng Qi Li, Bu Er Li, Ting Ting Lv, Shu Xiang Li, Shan Shan, Min Li, Yuan Yuan Kong, Dong Zhang, Hong Ma, Xiao Juan Ou, Hong You, Wei Jia Duan, Ji Dong Jia
    Journal of Digestive Diseases.2023; 24(6-7): 419.     CrossRef
  • Reciprocal alterations in circulating and hepatic gamma–delta T cells in patients with primary biliary cholangitis
    Sha Chen, Tingting Lv, Guangyong Sun, Shuxiang Li, Weijia Duan, Chunpan Zhang, Hua Jin, Dan Tian, Mingyang Li, Shan Shan, Hong Ma, Xiaojuan Ou, Hong You, Dong Zhang, Jidong Jia
    Hepatology International.2022; 16(1): 195.     CrossRef
  • KASL clinical practice guidelines for management of chronic hepatitis B

    Clinical and Molecular Hepatology.2022; 28(2): 276.     CrossRef
  • Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration
    Jung Hee Kim, Sung-Eun Kim, Do-Seon Song, Hee-Yeon Kim, Eileen Yoon, Tae-Hyung Kim, Young-Kul Jung, Ki Tae Suk, Baek-Gyu Jun, Hyung-Joon Yim, Jung-Hyun Kwon, Sung-Won Lee, Seong-Hee Kang, Moon-Young Kim, Soung-Won Jeong, Jae-Young Jang, Jeong-Ju Yoo, Sang
    Journal of Clinical Medicine.2022; 11(9): 2463.     CrossRef
  • Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis
    Sha Chen, Meng-Qi Li, Wei-Jia Duan, Bu-Er Li, Shu-Xiang Li, Ting-Ting Lv, Lin Ma, Ji-Dong Jia
    Hepatobiliary & Pancreatic Diseases International.2022; 21(6): 577.     CrossRef
  • Expression Patterns of Tumor Markers in Liver Transplant Recipients Showing Complete Pathological Response of Hepatocellular Carcinoma
    Min-Jae Kim, Woo-Hyoung Kang, Shin Hwang, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park
    Journal of Clinical Medicine.2022; 11(19): 5897.     CrossRef
  • First experience of liver transplantation for HIV-positive patients in Russia
    M. S. Novruzbekov, V. A. Gulyaev, A. I. Mazus, E. V. Ivannikov, M. S. Yadrikhinskaya, K. N. Lutsyk, O. D. Olisov, R. B. Akhmetshin, K. M. Magomedov, B. I. Kazymov, A. R. Akhmedov, K. F. Alekberov, B. I. Yaremin
    Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2022; 12(6): 139.     CrossRef
  • Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
    Hye Yeon Chon, Jae Seung Lee, Hye Won Lee, Ho Soo Chun, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
    Hepatology Research.2021; 51(4): 406.     CrossRef
  • Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites
    Jin Wook Lee, Jae Seok Hwang, Woo Jin Chung, Heon Ju Lee, Jung Gil Park, Chang Hyeong Lee, Byung Seok Kim, Jeong Eun Song, Young Oh Kweon, Won Young Tak, Soo Young Park, Se Young Jang, Jeong Ill Suh, Byoung Kuk Jang, Bhagwan Dass
    PLOS ONE.2021; 16(6): e0253886.     CrossRef
  • Effectiveness and safety of elbasvir/grazoprevir in Korean patients with hepatitis C virus infection: a nationwide real-world study
    Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook-Hyang Jeong
    The Korean Journal of Internal Medicine.2021; 36(Suppl 1): S1.     CrossRef
  • Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
    Han Ah Lee, Young-Sun Lee, Beom Kyung Kim, Young Kul Jung, Seung Up Kim, Jun Yong Park, Ji Hoon Kim, Hyunggin An, Do Young Kim, Hyung Joon Yim, Sang Hoon Ahn, Jong Eun Yeon, Kwan Soo Byun, Kwang-Hyub Han, Soon Ho Um, Yeon Seok Seo
    Gut and Liver.2021; 15(3): 420.     CrossRef
  • Guidelines for Prevention and Treatment of Chronic Hepatitis B
    Guiqiang Wang, Zhongping Duan
    Journal of Clinical and Translational Hepatology.2021; 000(000): 000.     CrossRef
  • The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
    Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
  • Diagnosis and Management of Esophageal and Gastric Variceal Bleeding: Focused on 2019 KASL Clinical Practice Guidelines for Liver Cirrhosis
    Min Kyung Park, Yun Bin Lee
    The Korean Journal of Gastroenterology.2021; 78(3): 152.     CrossRef
  • KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

    Clinical and Molecular Hepatology.2020; 26(2): 83.     CrossRef
  • Ultrasonographic morphological diagnosis of chronic liver disease: 2-dimensional shear wave elastography as an add-on test
    Young Seo Cho, Woo Kyoung Jeong, Yongsoo Kim
    Ultrasonography.2020; 39(3): 272.     CrossRef
  • Toward Quantitative and Operator-independent Quasi-static Ultrasound Elastography: An Ex Vivo Feasibility Study
    Sathiyamoorthy Selladurai, Abhilash Verma, Arun K. Thittai
    Ultrasonic Imaging.2020; 42(4-5): 179.     CrossRef
  • A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B Virus
    Min Cong, Xiaojuan Ou, Jian Huang, Jiang Long, Tong Li, Xueen Liu, Yanhong Wang, Xiaoning Wu, Jialing Zhou, Yameng Sun, Qinghua Shang, Guofeng Chen, Hui Ma, Wen Xie, Hongxin Piao, Yongping Yang, Zhiliang Gao, Xiaoyuan Xu, Zongnan Tan, Chitty Chen, Na Zeng
    OMICS: A Journal of Integrative Biology.2020; 24(7): 415.     CrossRef
  • Serum small extracellular vesicle‐derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma
    Soon Sun Kim, Geum Ok Baek, Hye Ri Ahn, Suna Sung, Chul Won Seo, Hyo Jung Cho, Suk Woo Nam, Jae Youn Cheong, Jung Woo Eun
    Molecular Oncology.2020; 14(10): 2646.     CrossRef
  • Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding
    Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Hyung Joon Yim, Young Kul Jung, Jin Mo Yang, Do Seon Song, Young Seok Kim, Sang Gyune Kim, Dong Joon Kim, Ki Tae Suk, Eileen L. Yoon, Sang Soo Lee, Chang Wook Kim, Hee Yeon Kim, Jae Young Jang, Soung Won Jeong
    Clinical and Molecular Hepatology.2020; 26(4): 540.     CrossRef
  • Managing liver cirrhotic complications: Overview of esophageal and gastric varices
    Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani
    Clinical and Molecular Hepatology.2020; 26(4): 444.     CrossRef
  • Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose
    Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook-Hyang Jeong
    Gut and Liver.2020; 14(6): 775.     CrossRef
  • The changing epidemiology of liver diseases in the Asia–Pacific region
    Martin C. S. Wong, Jason L. W. Huang, Jacob George, Junjie Huang, Colette Leung, Mohammed Eslam, Henry L. Y. Chan, Siew C. Ng
    Nature Reviews Gastroenterology & Hepatology.2019; 16(1): 57.     CrossRef
  • Fibrosis‐matched outcomes between chronic hepatitis B patients with drug‐induced virological response and inactive carriers
    Hye Soo Kim, Oidov Baatarkhuu, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kijun Song, Kwang‐Hyub Han, Beom Kyung Kim, Seung Up Kim
    Liver International.2019; 39(1): 81.     CrossRef
  • Towards quantitative quasi-static ultrasound elastography using a reference layer for liver imaging application: A preliminary assessment
    Sathiyamoorthy Selladurai, Arun K. Thittai
    Ultrasonics.2019; 93: 7.     CrossRef
  • Prognosis of 732 ursodeoxycholic acid‐treated patients with primary biliary cholangitis: A single center follow‐up study from China
    Sha Chen, Weijia Duan, Min Li, Shuxiang Li, Tingting Lv, Qiuju Tian, Qianyi Wang, Xiaoning Wu, Xinyan Zhao, Xiaoming Wang, Yu Wang, Yuanyuan Kong, Hong Ma, Xiaojuan Ou, Hong You, Jidong Jia
    Journal of Gastroenterology and Hepatology.2019; 34(7): 1236.     CrossRef
  • Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model
    Tatsuro Nishimura, Taro Takami, Ryo Sasaki, Yuki Aibe, Takashi Matsuda, Koichi Fujisawa, Toshihiko Matsumoto, Naoki Yamamoto, Kenji Tani, Yasuho Taura, Isao Sakaida, Matias A Avila
    PLOS ONE.2019; 14(1): e0210588.     CrossRef
  • Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology
    Dong-Hwan Jung, Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Gi-Won Song, Chul-Soo Ahn, Deok-Bog Moon, Sung-Gyu Lee
    Annals of Surgery.2019; 269(3): 511.     CrossRef
  • Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis
    Haripriya Gupta, Gi Soo Youn, Sang Hak Han, Min Jea Shin, Sang Jun Yoon, Dae Hee Han, Na Young Lee, Dong Joon Kim, Soon Koo Baik, Ki Tae Suk
    Journal of Clinical Medicine.2019; 8(6): 862.     CrossRef
  • KASL clinical practice guidelines for management of chronic hepatitis B

    Clinical and Molecular Hepatology.2019; 25(2): 93.     CrossRef
  • Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN)
    Ji Hoon Park, Mi-Suk Park, So Jung Lee, Woo Kyoung Jeong, Jae Young Lee, Min Jung Park, Sung Soo Lee, Kyunghwa Han, Chung Mo Nam, Seong Ho Park, Kyoung Ho Lee
    Radiology.2019; 292(3): 638.     CrossRef
  • Current approaches to the management of patients with cirrhotic ascites
    Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev
    World Journal of Gastroenterology.2019; 25(28): 3738.     CrossRef
  • The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients
    Tae Yeob Kim, Ki Tae Suk, Soung Won Jeong, Tom Ryu, Dong Joon Kim, Soon Koo Baik, Joo Hyun Sohn, Woo Kyoung Jeong, Eunhee Choi, Jae Young Jang, Moon Young Kim
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Real‐life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance‐associated substitution test
    Eun Sun Jang, Kyung‐Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook‐Hyang Jeong
    Journal of Medical Virology.2019; 91(12): 2158.     CrossRef
  • Natural History and Treatment Indications of Chronic Hepatitis B
    Dong Hyun Sinn
    The Korean Journal of Gastroenterology.2019; 74(5): 245.     CrossRef
  • Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
    Mi Young Jeon, Hye Won Lee, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn
    Liver International.2018; 38(4): 676.     CrossRef
  • Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study
    Ki Tae Suk, Moon Young Kim, Soung Won Jeong, Jae Young Jang, Yoon Ok Jang, Soon Koo Baik
    Digestive Diseases and Sciences.2018; 63(1): 248.     CrossRef
  • Utility and Limitations of Glycated Hemoglobin (HbA1c) in Patients with Liver Cirrhosis as Compared with Oral Glucose Tolerance Test for Diagnosis of Diabetes
    Tejasav Sehrawat, Anuraag Jindal, Paaras Kohli, Amit Thour, Jasbinder Kaur, Atul Sachdev, Yashdeep Gupta
    Diabetes Therapy.2018; 9(1): 243.     CrossRef
  • Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy
    Joohwan Bae, Dong Hyun Sinn, Wonseok Kang, Geum‐Youn Gwak, Moon Seok Choi, Yong‐Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
    Liver International.2018; 38(8): 1442.     CrossRef
  • Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA
    Weijia Duan, Xiaojuan Ou, Xiaoming Wang, Yu Wang, Xinyan Zhao, Qianyi Wang, Xiaoning Wu, Wei Zhang, Hong Ma, Hong You, Jidong Jia
    Revista Española de Enfermedades Digestivas.2018;[Epub]     CrossRef
  • Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D
    Eun Sun Jang, Young Seok Kim, Kyung-Ah Kim, Youn Jae Lee, Woo Jin Chung, In Hee Kim, Byung Seok Lee, Sook-Hyang Jeong
    Gut and Liver.2018; 12(4): 440.     CrossRef
  • Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis
    Sung-Eun Kim, Ji Won Park, Mo-Jong Kim, Byungki Jang, Yong-Chul Jeon, Hee-Jun Kim, Akihito Ishigami, Hyoung Su Kim, Ki Tae Suk, Dong Joon Kim, Choong Kee Park, Eun-Kyoung Choi, Myoung-Kuk Jang, Leo A. van Grunsven
    PLOS ONE.2018; 13(8): e0201744.     CrossRef
  • KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

    Clinical and Molecular Hepatology.2018; 24(3): 230.     CrossRef
  • 2017 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines for Ascites and Related Complications: What Has Been Changed from the 2011 KASL Clinical Practice Guidelines?
    Yeon Seok Seo
    The Korean Journal of Gastroenterology.2018; 72(4): 179.     CrossRef
  • Iron metabolism disorders in patients with hepatitis B-related liver diseases
    Yan-Hang Gao, Jing-Yun Wang, Pei-Yan Liu, Jing Sun, Xiao-Mei Wang, Rui-Hong Wu, Xiu-Ting He, Zheng-Kun Tu, Chun-Guang Wang, Hong-Qin Xu, Jun-Qi Niu
    World Journal of Clinical Cases.2018; 6(13): 600.     CrossRef
  • Investigation on outcomes and bacterial distributions of liver cirrhosis patients with gram-negative bacterial bloodstream infection
    Yangxin Xie, Bo Tu, Xin Zhang, Jingfeng Bi, Lei Shi, Peng Zhao, Weiwei Chen, Suxia Liu, Dongping Xu, Enqiang Qin
    Oncotarget.2018; 9(3): 3980.     CrossRef
  • Alcoholic Liver Disease Is Associated with an Increased Risk of Gastric Cancer
    Tae Hoon Ha, Byeong Gwan Kim, Donghyong Jeong, Sohee Oh, Won Kim, Yong Jin Jung, Dong Won Ahn, Ji Bong Jeong, Ji Won Kim, Kook Lae Lee, Seong-Joon Koh
    Digestive Diseases and Sciences.2017; 62(1): 273.     CrossRef
  • Comparison of clinical characteristics and outcomes of spontaneous bacterial peritonitis and culture negative neutrocytic ascites
    Sun Hee Na, Eun Jung Kim, Eun Young Nam, Kyoung-Ho Song, Pyoeng Gyun Choe, Wan Beom Park, Ji Hwan Bang, Eu Suk Kim, Sang Won Park, Hong Bin Kim, Myoung-don Oh, Nam Joong Kim
    Scandinavian Journal of Gastroenterology.2017; 52(2): 199.     CrossRef
  • Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis
    Eui Joo Kim, Jong Eun Yeon, Oh Sang Kwon, Heon Nam Lee, Seung Kak Shin, Seong Hee Kang, Kwan Soo Byun, Jeong Han Kim, So Young Kwon, Sang Jun Suh, Hyung Joon Yim, Yun Soo Kim, Ju Hyun Kim
    Digestive Diseases and Sciences.2017; 62(3): 808.     CrossRef
  • Clinical Features of Spontaneous Bacterial Peritonitis: A 10-year Experience from a Single Center
    Ha Young Na, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Byung-chul Yoo
    The Korean Journal of Gastroenterology.2017; 69(2): 129.     CrossRef
  • Do We Need to Change the Treatment Strategy for Spontaneous Bacterial Peritonitis in Patients with Advanced Cirrhosis?
    Chang Wook Kim
    The Korean Journal of Gastroenterology.2017; 69(2): 93.     CrossRef
  • Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial
    Ji Hoon Park, Mi-Suk Park, So Jung Lee, Woo Kyoung Jeong, Jae Young Lee, Min Jung Park, Kyunghwa Han, Chung Mo Nam, Seong Ho Park, Kyoung Ho Lee
    BMC Cancer.2017;[Epub]     CrossRef
  • Prognostic effect of transarterial chemoembolization–induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma
    Woo‐Hyoung Kang, Shin Hwang, Gi‐Won Song, Young‐Joo Lee, Ki‐Hun Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Dong‐Hwan Jung, Gil‐Chun Park, Sung‐Gyu Lee
    Liver Transplantation.2017; 23(6): 781.     CrossRef
  • Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era
    Eun Sun Jang, Young Seok Kim, Kyung-Ah Kim, Youn Jae Lee, Woo Jin Chung, In Hee Kim, Byung Seok Lee, Sook-Hyang Jeong
    Gut and Liver.2017; 11(4): 543.     CrossRef
  • Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues
    Dong Joon Kim, Moon Seok Choi
    Clinical and Molecular Hepatology.2017; 23(2): 115.     CrossRef
  • 3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy
    Chang Hun Lee, In Hee Kim, Jin Chang Moon, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae Ghon Kim, Jae Do Yang, Hee Chul Yu
    World Journal of Gastroenterology.2017; 23(2): 297.     CrossRef
  • Liver cirrhosis caused by chronic Budd–Chiari syndrome
    Mengjie Lin, Feng Zhang, Yi Wang, Bin Zhang, Wei Zhang, Xiaoping Zou, Ming Zhang, Yuzheng Zhuge
    Medicine.2017; 96(34): e7425.     CrossRef
  • Hospice and Palliative Care in End Stage Liver Disease
    Moon Young Kim
    The Korean Journal of Hospice and Palliative Care.2017; 20(3): 167.     CrossRef
  • Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B
    Wei Zhang, Xiaoming Wang, Yu Wang, Xinyan Zhao, Weijia Duan, Qianyi Wang, Xiaoning Wu, Yuanyuan Kong, Hong Ma, Hong You, Xiaojuan Ou, Jidong Jia
    Medicine.2017; 96(44): e8454.     CrossRef
  • Useful Endoscopic Ultrasonography Parameters and a Predictive Model for the Recurrence of Esophageal Varices and Bleeding after Variceal Ligation
    Soung Won Jeong, Hye Soo Kim, Sang Gyune Kim, Jeong-Ju Yoo, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Ji Sung Lee, Young Seok Kim, Boo Sung Kim
    Gut and Liver.2017; 11(6): 843.     CrossRef
  • FATORES PROGNÓSTICOS E MORTALIDADE EM PACIENTES CIRRÓTICOS QUE FORAM INTERNADOS COM HEMORRAGIA DIGESTIVA ALTA VARICOSA EM UM HOSPITAL PÚBLICO
    Haroldo Luiz Jordelino da Luz, Caroline de Medeiros Linhares, Luana Fanha Souto, Bruna Luiza Zonta Ximenes Canfield, Ariane Badotti
    Arquivos Catarinenses de Medicina.2017; 46(1): 97.     CrossRef
  • Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis
    Tae Yeob Kim, Jae Gon Lee, Joo Hyun Sohn, Ji Yeoun Kim, Sun Min Kim, Jinoo Kim, Woo Kyoung Jeong
    Yonsei Medical Journal.2016; 57(1): 138.     CrossRef
  • The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?
    Sun Young Yim, Yeon Seok Seo, Chang Ho Jung, Tae Hyung Kim, Jae Min Lee, Eun Sun Kim, Bora Keum, Young Kul Jong, Hyunggin An, Ji Hoon Kim, Hyung Joon Yim, Dong Sik Kim, Yoon Tae Jeen, Jong Eun Yeon, Hong Sik Lee, Hoon Jai Chun, Kwan Soo Byun, Soon Ho Um,
    Liver International.2016; 36(3): 445.     CrossRef
  • Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma
    Tae‐Yong Ha, Shin Hwang, Young‐Joo Lee, Ki‐Hun Kim, Gi‐Young Ko, Dong II Gwon, Chul‐Soo Ahn, Deok‐Bog Moon, Gi‐Won Song, Dong‐Hwan Jung, Han Chu Lee, Young‐Suk Lim, Kang Mo Kim, Ju Hyun Shim, Jeong‐Heon Choi, Sung‐Gyu Lee
    World Journal of Surgery.2016; 40(5): 1200.     CrossRef
  • Proton Pump Inhibitor Therapy Is Associated With Reduction of Early Bleeding Risk After Prophylactic Endoscopic Variceal Band Ligation
    Seong Hee Kang, Hyung Joon Yim, Seung Young Kim, Sang Jun Suh, Jong Jin Hyun, Sung Woo Jung, Young Kul Jung, Ja Seol Koo, Sang Woo Lee
    Medicine.2016; 95(8): e2903.     CrossRef
  • Variceal Bleeding from Anastomosis Site after Total Gastrectomy with Esophagojejunostomy
    Jung Woong Seo, Jeong Han Kim
    The Korean Journal of Gastroenterology.2016; 67(6): 341.     CrossRef
  • Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma
    Jung Hee Kim, Dong Hyun Sinn, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
    Digestive Diseases and Sciences.2016; 61(11): 3354.     CrossRef
  • Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
    Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han, Sang Hoon Ahn
    Clinical Gastroenterology and Hepatology.2016; 14(11): 1647.     CrossRef
  • Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease
    Bong Jin Ko, Young Seok Kim, Sang Gyune Kim, Jung Hwan Park, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim, Sun Mi Kim, Young Don Kim, Gab Jin Cheon, Bo Ra Lee
    Gut and Liver.2016; 10(5): 818.     CrossRef
  • Transplantation with autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial
    Ki Tae Suk, Jung‐Hwan Yoon, Moon Young Kim, Chang Wook Kim, Ja Kyung Kim, Hana Park, Seong Gyu Hwang, Dong Joon Kim, Byung Seok Lee, Sae Hwan Lee, Hong Soo Kim, Jae Young Jang, Chang‐Hyeong Lee, Byung Seok Kim, Yoon Ok Jang, Mee Yon Cho, Eun Sun Jung, Yon
    Hepatology.2016; 64(6): 2185.     CrossRef
  • Usefulness of Ultrasonographic Scoring System in Diagnosis of Alcoholic Cirrhosis
    Kyoung Min Moon, Soon Koo Baik
    Clinical Ultrasound.2016; 1(2): 92.     CrossRef
  • Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition
    Tae Yeob Kim, Do Seon Song, Hee Yeon Kim, Dong Hyun Sinn, Eileen L. Yoon, Chang Wook Kim, Young Kul Jung, Ki Tae Suk, Sang Soo Lee, Chang Hyeong Lee, Tae Hun Kim, Jeong Han Kim, Won Hyeok Choe, Hyung Joon Yim, Sung Eun Kim, Soon Koo Baik, Byung Seok Lee,
    PLOS ONE.2016; 11(1): e0146745.     CrossRef
  • Clinical features of acute hepatitis E super-infections on chronic hepatitis B
    Chong Chen, Shu-Ye Zhang, Dan-Dan Zhang, Xin-Yan Li, Yu-Ling Zhang, Wei-Xia Li, Jing-Jing Yan, Min Wang, Jing-Na Xun, Chuan Lu, Yun Ling, Yu-Xian Huang, Liang Chen
    World Journal of Gastroenterology.2016; 22(47): 10388.     CrossRef
  • Long-Term Suppression of Viral Replication in Chronic Hepatitis B: Outcomes and Future Directions
    Jae-Jun Shim
    Gut and Liver.2015;[Epub]     CrossRef
  • Prognostic effect of preoperative sequential transcatheter arterial chemoembolization and portal vein embolization for right hepatectomy in patients with solitary hepatocellular carcinoma
    Jeong-Heon Choi, Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Gi-Young Ko, Dong Il Gwon, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Sung-Gyu Lee
    Korean Journal of Hepato-Biliary-Pancreatic Surgery.2015; 19(2): 59.     CrossRef
  • The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
    In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
    Clinical and Molecular Hepatology.2015; 21(1): 32.     CrossRef
  • The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients
    Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Sung-Gyu Lee
    Journal of Gastrointestinal Surgery.2015; 19(7): 1281.     CrossRef
  • Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy
    Jin Chang Moon, Seong Hun Kim, In Hee Kim, Chang Hun Lee, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae-Ghon Kim
    Gut and Liver.2015;[Epub]     CrossRef
  • Lower Incidence of Hepatocellular Carcinoma and Cirrhosis in Hepatitis C Patients with Sustained Virological Response by Pegylated Interferon and Ribavirin
    Chansoo Moon, Kyu Sik Jung, Do Young Kim, Oidov Baatarkhuu, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Sang Hoon Ahn, Kwang-Hyub Han
    Digestive Diseases and Sciences.2015; 60(2): 573.     CrossRef
  • Improvement of liver function and non‐invasive fibrosis markers in hepatitis B virus‐associated cirrhosis: 2 years of entecavir treatment
    Seung Kak Shin, Jeong Han Kim, Hyeonsu Park, Oh Sang Kwon, Hyun Jung Lee, Jong Eun Yeon, Kwan Soo Byun, Sang Jun Suh, Hyung Joon Yim, Yun Soo Kim, Ju Hyun Kim
    Journal of Gastroenterology and Hepatology.2015; 30(12): 1775.     CrossRef
  • Evaluation of portal hypertension by real‐time shear wave elastography in cirrhotic patients
    Tae Yeob Kim, Woo Kyoung Jeong, Joo Hyun Sohn, Jinoo Kim, Min Yeong Kim, Yongsoo Kim
    Liver International.2015; 35(11): 2416.     CrossRef
  • Liver Stiffness Measurement, Better than APRI, Fibroindex, Fib-4, and NBI Gastroscopy, Predicts Portal Hypertension in Patients with Cirrhosis
    Wei Zhang, Liqiong Wang, Lei Wang, Gang Li, Aoshuang Huang, Ping Yin, Zhenhua Yang, Changquan Ling, Lingtai Wang
    Cell Biochemistry and Biophysics.2015; 71(2): 865.     CrossRef
  • What we know about paracentesis induced circulatory dysfunction?
    Jeong Han Kim
    Clinical and Molecular Hepatology.2015; 21(4): 349.     CrossRef
  • Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
    Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong
    Clinical and Molecular Hepatology.2014; 20(4): 347.     CrossRef
  • Prevention of Variceal Rebleeding According to the Dose of Propranolol
    Jae Young Jang, Woong Cheul Lee
    Korean Journal of Medicine.2014; 86(1): 30.     CrossRef
  • Sarcopenia as a Useful Predictor for Long-Term Mortality in Cirrhotic Patients with Ascites
    Tae Yeob Kim, Min Yeong Kim, Joo Hyun Sohn, Sun Min Kim, Jeong Ah Ryu, Sanghyeok Lim, Youngsoo Kim
    Journal of Korean Medical Science.2014; 29(9): 1253.     CrossRef
  • Clinically Severe Portal Hypertension: Role of Multi-detector Row CT Features in Diagnosis
    Ji Young Lee, Tae Yeob Kim, Woo Kyoung Jeong, Yongsoo Kim, Jinoo Kim, Kyoung Won Kim, Young Hwan Kim, Joo Hyun Sohn
    Digestive Diseases and Sciences.2014; 59(9): 2333.     CrossRef
  • Cyanoacrylate Injection Compared with Band Ligation for Acute Gastric Variceal Hemorrhage: A Meta-Analysis of Randomized Controlled Trials and Observational Studies
    Xiaohua Ye, Jiaping Huai, Yanping Chen
    Gastroenterology Research and Practice.2014; 2014: 1.     CrossRef
  • Clinical Features of Non-alcoholic Fatty Liver Disease in Cryptogenic Hepatocellular Carcinoma
    Min Young Rim, Oh Sang Kwon, Minsu Ha, Ju Seung Kim, Kwang Il Ko, Dong Kyu Kim, Pil Kyu Jang, Jung Yoon Han, Pyung Hwa Park, Young Kul Jung, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
    The Korean Journal of Gastroenterology.2014; 63(5): 292.     CrossRef
  • Histological improvement following administration of autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study
    Yoon Ok Jang, Young Ju Kim, Soon Koo Baik, Moon Young Kim, Young Woo Eom, Mee Yon Cho, Hong Jun Park, So Yeon Park, Bo Ra Kim, Jae Woo Kim, Hyun Soo Kim, Sang Ok Kwon, Eun Hee Choi, Yong Man Kim
    Liver International.2014; 34(1): 33.     CrossRef
  • Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
    Won Ki Hong, Kwang Yong Shim, Soon Koo Baik, Moon Young Kim, Mee Yon Cho, Yoon Ok Jang, Young Shik Park, Jin Han, Gaeun Kim, Youn Zoo Cho, Hye Won Hwang, Jin Hyung Lee, Myeong Hun Chae, Sang Ok Kwon
    Journal of Korean Medical Science.2014; 29(3): 392.     CrossRef
  • Use of the Delta Neutrophil Index as a Prognostic Factor of Mortality in Patients with Spontaneous Bacterial Peritonitis: Implications of a Simple and Useful Marker
    Tae Seop Lim, Beom Kyung Kim, Jong Wook Lee, Young Ki Lee, Sooyun Chang, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon, Jun Yong Park, Charles C. Caldwell
    PLoS ONE.2014; 9(1): e86884.     CrossRef
  • Alcoholic liver disease: Treatment
    Ki Tae Suk
    World Journal of Gastroenterology.2014; 20(36): 12934.     CrossRef
  • Association of polymorphism in MicroRNA 219‐1 with clearance of hepatitis B virus infection
    Jae Youn Cheong, Hyoung Doo Shin, Yoon Jun Kim, Sung Won Cho
    Journal of Medical Virology.2013; 85(5): 808.     CrossRef
  • Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection
    Chang Bum Bae, Soon Sun Kim, Seun Joo Ahn, Hyo Jung Cho, Sei Rhan Kim, Sun Young Park, Ga Won Song, Dong Joon Kim, Seong Gyu Hwang, Jin Mo Yang, Young Bae Kim, Young Nyun Park, Sung Jae Shin, Sung Won Cho, Jae Youn Cheong
    Journal of Clinical Virology.2013; 58(4): 641.     CrossRef
  • The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data
    Won Ki Hong, Moon Young Kim, Soon Koo Baik, Seung Yong Shin, Jung Min Kim, Yong Seok Kang, Yoo Li Lim, Young Ju Kim, Youn Zoo Cho, Hye Won Hwang, Jin Hyung Lee, Myeong Hun Chae, Hyoun A Kim, Hye Won Kang, Sang Ok Kwon
    Clinical and Molecular Hepatology.2013; 19(4): 370.     CrossRef
  • Prevention and Management of Variceal Hemorrhage
    Dong Hyun Kim, Jun Yong Park
    International Journal of Hepatology.2013; 2013: 1.     CrossRef
  • Comparison of Endoscopic Variceal Ligation and Endoscopic Variceal Obliteration in Patients with GOV1 Bleeding
    Hyoung Ju Hong, Chung Hwan Jun, Du Hyeon Lee, Eun Ae Cho, Seon Young Park, Sung Bum Cho, Chang Hwan Park, Young Eun Joo, HyunSoo Kim, Sung Kyu Choi, Jong Sun Rew
    Chonnam Medical Journal.2013; 49(1): 14.     CrossRef
  • The Korean National Liver Cancer Surveillance Program: Experience of a Single Healthcare Center in 2011
    Jae-Jun Shim, Hyun Jin Park, Jung-Wook Kim, Eun Jung Hwang, Chang Kyun Lee, Jae Young Jang, Seong Jin Park, Hyun Rim Choi, Byung-Ho Kim
    Korean Journal of Medicine.2013; 84(5): 672.     CrossRef
  • Spontaneous Healing of Gastric Perforation after Endoscopic Ligation for Gastric Varices
    Jung Ho Kim, Hong Dae Ahn, Kwang An Kwon, Yoon Jae Kim, Jun-Won Chung, Dong Kyun Park, Ju Hyun Kim
    Journal of Korean Medical Science.2013; 28(4): 624.     CrossRef
  • A Case of Spontaneous Bacterial Peritonitis Caused byListeria monocytogenes
    Byung Sihk Kim, Tae Yeob Kim, Ji Yeoun Kim, Kyo Sang Yoo, Yong Chul Jeon, Dong Soo Han, Joo Hyun Sohn, Jieun Kim
    The Korean Journal of Gastroenterology.2013; 62(3): 179.     CrossRef
  • Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study
    Se Young Jang, Go Heun Kim, Soo Young Park, Chang Min Cho, Won Young Tak, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Jae Myeong Lee, Sang Gyune Kim, Dae Yong Kim, Young Seok Kim, Se-Ok Lee, Yang Won Min, Joon Hyeok Lee, Seung Woon Paik, Byung Chul Yoo,
    Clinical and Molecular Hepatology.2012; 18(4): 368.     CrossRef
  • Spontaneous Bacterial Peritonitis with Sepsis Caused byEnterococcus hirae
    Jong Seop Sim, Hyoung Su Kim, Ki Jong Oh, Myung Soo Park, Eun Ju Jung, Youn Joo Jung, Dae Gil Kang, Seung In Seo, Won Jin Kim, Myoung Kuk Jang
    Journal of Korean Medical Science.2012; 27(12): 1598.     CrossRef
  • 65,535 View
  • 191 Download
  • Crossref